vs
Side-by-side financial comparison of Fortive (FTV) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
Fortive is the larger business by last-quarter revenue ($1.1B vs $1.1B, roughly 1.0× PERRIGO Co plc). Fortive runs the higher net margin — 16.5% vs -127.8%, a 144.3% gap on every dollar of revenue. On growth, Fortive posted the faster year-over-year revenue change (4.6% vs -2.5%). Fortive produced more free cash flow last quarter ($313.8M vs $148.6M). Over the past eight quarters, PERRIGO Co plc's revenue compounded faster (1.3% CAGR vs -14.2%).
Fortive Corporation is an American industrial technology conglomerate company headquartered in Everett, Washington. The company specializes in providing essential technologies for connected workflow solutions; designing, developing, manufacturing and distributing professional and engineered products, software and services. Their products and services are split into three strategic segments; Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. As of Decem...
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
FTV vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.1B |
| Net Profit | $185.7M | $-1.4B |
| Gross Margin | 63.2% | 32.6% |
| Operating Margin | 20.1% | -116.0% |
| Net Margin | 16.5% | -127.8% |
| Revenue YoY | 4.6% | -2.5% |
| Net Profit YoY | 10.4% | -3093.9% |
| EPS (diluted) | $0.60 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $1.1B | ||
| Q3 25 | $1.0B | $1.0B | ||
| Q2 25 | $1.5B | $1.1B | ||
| Q1 25 | $1.5B | $1.0B | ||
| Q4 24 | $1.6B | $1.1B | ||
| Q3 24 | $1.5B | $1.1B | ||
| Q2 24 | $1.6B | $1.1B | ||
| Q1 24 | $1.5B | $1.1B |
| Q4 25 | $185.7M | $-1.4B | ||
| Q3 25 | $55.0M | $7.5M | ||
| Q2 25 | $166.6M | $-8.4M | ||
| Q1 25 | $171.9M | $-6.4M | ||
| Q4 24 | $208.8M | $-44.4M | ||
| Q3 24 | $221.6M | $-21.0M | ||
| Q2 24 | $195.1M | $-108.4M | ||
| Q1 24 | $207.4M | $2.0M |
| Q4 25 | 63.2% | 32.6% | ||
| Q3 25 | 63.2% | 36.1% | ||
| Q2 25 | 59.0% | 34.4% | ||
| Q1 25 | 59.8% | 37.6% | ||
| Q4 24 | 60.3% | 33.9% | ||
| Q3 24 | 60.0% | 37.2% | ||
| Q2 24 | 59.8% | 37.0% | ||
| Q1 24 | 59.3% | 33.1% |
| Q4 25 | 20.1% | -116.0% | ||
| Q3 25 | 15.5% | 7.0% | ||
| Q2 25 | 14.6% | 4.3% | ||
| Q1 25 | 15.8% | 4.5% | ||
| Q4 24 | 19.0% | 10.0% | ||
| Q3 24 | 19.3% | 7.4% | ||
| Q2 24 | 19.4% | -2.5% | ||
| Q1 24 | 19.8% | -5.1% |
| Q4 25 | 16.5% | -127.8% | ||
| Q3 25 | 5.4% | 0.7% | ||
| Q2 25 | 11.0% | -0.8% | ||
| Q1 25 | 11.7% | -0.6% | ||
| Q4 24 | 12.9% | -3.9% | ||
| Q3 24 | 14.4% | -1.9% | ||
| Q2 24 | 12.6% | -10.2% | ||
| Q1 24 | 13.6% | 0.2% |
| Q4 25 | $0.60 | $-10.23 | ||
| Q3 25 | $0.16 | $0.05 | ||
| Q2 25 | $0.49 | $-0.06 | ||
| Q1 25 | $0.50 | $-0.05 | ||
| Q4 24 | $0.60 | $-0.32 | ||
| Q3 24 | $0.63 | $-0.15 | ||
| Q2 24 | $0.55 | $-0.79 | ||
| Q1 24 | $0.58 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.5M | — |
| Total DebtLower is stronger | $3.2B | — |
| Stockholders' EquityBook value | $6.5B | $2.9B |
| Total Assets | $11.7B | $8.5B |
| Debt / EquityLower = less leverage | 0.50× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.5M | — | ||
| Q3 25 | $430.8M | $432.1M | ||
| Q2 25 | $1.8B | $454.2M | ||
| Q1 25 | $892.1M | $409.9M | ||
| Q4 24 | $813.3M | $558.8M | ||
| Q3 24 | $811.3M | $1.5B | ||
| Q2 24 | $644.1M | $542.8M | ||
| Q1 24 | $704.6M | $658.5M |
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.3B | — | ||
| Q2 25 | $4.8B | — | ||
| Q1 25 | $3.9B | — | ||
| Q4 24 | $3.7B | — | ||
| Q3 24 | $3.9B | — | ||
| Q2 24 | $3.8B | — | ||
| Q1 24 | $3.9B | — |
| Q4 25 | $6.5B | $2.9B | ||
| Q3 25 | $6.5B | $4.4B | ||
| Q2 25 | $10.4B | $4.5B | ||
| Q1 25 | $10.2B | $4.4B | ||
| Q4 24 | $10.2B | $4.3B | ||
| Q3 24 | $10.6B | $4.6B | ||
| Q2 24 | $10.5B | $4.5B | ||
| Q1 24 | $10.5B | $4.7B |
| Q4 25 | $11.7B | $8.5B | ||
| Q3 25 | $11.9B | $10.1B | ||
| Q2 25 | $18.2B | $10.1B | ||
| Q1 25 | $17.1B | $9.8B | ||
| Q4 24 | $17.0B | $9.6B | ||
| Q3 24 | $17.5B | $11.2B | ||
| Q2 24 | $17.3B | $10.4B | ||
| Q1 24 | $17.5B | $10.6B |
| Q4 25 | 0.50× | — | ||
| Q3 25 | 0.51× | — | ||
| Q2 25 | 0.46× | — | ||
| Q1 25 | 0.38× | — | ||
| Q4 24 | 0.36× | — | ||
| Q3 24 | 0.37× | — | ||
| Q2 24 | 0.36× | — | ||
| Q1 24 | 0.38× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.1B | $175.4M |
| Free Cash FlowOCF − Capex | $313.8M | $148.6M |
| FCF MarginFCF / Revenue | 28.0% | 13.4% |
| Capex IntensityCapex / Revenue | 2.7% | 2.4% |
| Cash ConversionOCF / Net Profit | 5.83× | — |
| TTM Free Cash FlowTrailing 4 quarters | $956.4M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.1B | $175.4M | ||
| Q3 25 | $164.4M | $51.7M | ||
| Q2 25 | $311.2M | $75.9M | ||
| Q1 25 | $241.7M | $-64.5M | ||
| Q4 24 | $502.2M | $312.6M | ||
| Q3 24 | $459.0M | $42.2M | ||
| Q2 24 | $308.9M | $9.5M | ||
| Q1 24 | $256.7M | $-1.4M |
| Q4 25 | $313.8M | $148.6M | ||
| Q3 25 | $153.1M | $29.8M | ||
| Q2 25 | $274.5M | $56.7M | ||
| Q1 25 | $215.0M | $-90.0M | ||
| Q4 24 | $465.2M | $274.9M | ||
| Q3 24 | $431.2M | $15.1M | ||
| Q2 24 | $279.7M | $-18.9M | ||
| Q1 24 | $230.3M | $-26.5M |
| Q4 25 | 28.0% | 13.4% | ||
| Q3 25 | 14.9% | 2.9% | ||
| Q2 25 | 18.1% | 5.4% | ||
| Q1 25 | 14.6% | -8.6% | ||
| Q4 24 | 28.7% | 24.2% | ||
| Q3 24 | 28.1% | 1.4% | ||
| Q2 24 | 18.0% | -1.8% | ||
| Q1 24 | 15.1% | -2.4% |
| Q4 25 | 2.7% | 2.4% | ||
| Q3 25 | 1.1% | 2.1% | ||
| Q2 25 | 2.4% | 1.8% | ||
| Q1 25 | 1.8% | 2.4% | ||
| Q4 24 | 2.3% | 3.3% | ||
| Q3 24 | 1.8% | 2.5% | ||
| Q2 24 | 1.9% | 2.7% | ||
| Q1 24 | 1.7% | 2.3% |
| Q4 25 | 5.83× | — | ||
| Q3 25 | 2.99× | 6.89× | ||
| Q2 25 | 1.87× | — | ||
| Q1 25 | 1.41× | — | ||
| Q4 24 | 2.41× | — | ||
| Q3 24 | 2.07× | — | ||
| Q2 24 | 1.58× | — | ||
| Q1 24 | 1.24× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FTV
Segment breakdown not available.
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
